The 1st article is very important not only to the patient but also the out of control expenses of treating PCa. Mapping of the genome of PCa cells has been looked at extensively. Article #2 explains why more problems arise from Food and Drug Administration announcing it would be taking a closer look into safety reports regarding da Vinci surgical robots. Article #3 states: “Ros Eeles of Britain’s Institute of Cancer Research, an expert in prostate cancer, said the new findings were the biggest leap forward yet in understanding the genetic basis of the disease“. Article #5 is outstanding! “In a study involving 247 men with metastatic prostate cancer, researchers found that men who took blood-thinning medication in conjunction with chemotherapy survived for an average of almost 21 months, compared to a survival of approximately 17 months for those men who didn’t”.
1) New genetic testing for prostate cancer may reduce unnecessary treatment
published March 27, 2013
“Fortunately, a new report from the New York Times detailed how many more sophisticated prostate cancer tests will soon be on the market. One such test involves mapping the genome of the cancer itself, in an attempt to distinguish between the most dangerous of tumors and the ones that are slow-growing and do not pose as much of a health risk. The current PSA test is not very accurate in differentiating between the two, often highlighting tumors that don’t need to be treated”.
2) Robotic surgery tied to temporary nerve injuries
NEW YORK | Fri Mar 29, 2013 11:33pm
(Reuters Health) -” One in 15 people undergoing robot-assisted prostate, kidney or bladder surgery develops a nerve injury related to pressure from positioning on the operating table, a new study suggests.
“When somebody is in that position, there’s a chance they could slide down – it’s like a big ramp,” said lead author Dr. Tracey Krupski, from the University of Virginia School of Medicine in Charlottesville. “When you slide, you then could be pulling, or having the drag on some of the nerves. It’s like a constant pulling on the muscle.” Earlier this month, the Food and Drug Administration announced it would be taking a closer look into safety reports regarding da Vinci surgical robots, made by Intuitive Surgical. The robots cost about $1.5 million each.
3) Record gene haul points to better cancer screening
Wed Mar 27, 2013 9:30pm
“Ros Eeles of Britain’s Institute of Cancer Research, an expert in prostate cancer, said the new findings were the biggest leap forward yet in understanding the genetic basis of the disease. “They allow us, for the first time, to identify men who have a very high risk of developing prostate cancer during their lifetime through inheritance of multiple risk genetic variants,” she said. In the case of prostate cancer, scientists found 23 new genetic variations – known as single nucleotide polymorphisms, or SNPs – taking the total to 78. Significantly, 16 were linked with the more aggressive forms of the disease”.
4) New Prostate Cancer Tests Could Reduce False Alarms
Published: March 26, 2013
“Sophisticated new prostate cancer tests are coming to market that might supplement the unreliable P.S.A. test, potentially saving tens of thousands of men each year from unnecessary biopsies, operations and radiation treatments”.
5) Blood thinners might prolong life for prostate cancer patients
February 22, 2013
“In a study involving 247 men with metastatic prostate cancer, researchers found that men who took blood-thinning medication in conjunction with chemotherapy survived for an average of almost 21 months, compared to a survival of approximately 17 months for those men who didn’t.The findings, presented at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium on Feb. 14 to 16, were especially surprising to the researchers, who thought that the underlying conditions indicating blood-thinner use (deep vein thrombosis and pulmonary embolism) might have reduced survival time instead”.
I’m not afraid of death…….. staying alive is much harder!
The New Denver Men’s Club
University Prostate Cancer Support Group, Inc.
(please sign in at bottom to receive future blogs)